The proteome profiling services market is projected to be worth USD 16 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis

Proteome profiling is a technically complex and financially demanding field of research, as a result both pharmaceutical companies and research institutes prefer to rely on specialty service providers that claim to have the required expertise

Roots Analysis is pleased to announce the publication of its recent study, titled, “Proteome Profiling Services Market, 2020-2030.”

The report features an extensive study of the current market landscape and future opportunities associated with proteome profiling service providers. The study also features a detailed analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:

• A detailed review of the overall landscape of companies offering proteome profiling services, along with information on type of service provider, year of establishment, company size, location of headquarters, service(s) offered for pre-proteome profiling, service(s) offered for proteome profiling, other service(s) offered, type of product profiled and type of sample(s) used.
• Detailed profiles of prominent proteome profiling players (shortlisted on the basis of the number of pipeline services).
• An analysis of the partnerships that have been established in this domain, in the recent past.
• A competitiveness analysis of proteome profiling services, featuring insightful pictorial summaries and representations.
• An elaborate discussion on various factors contributing to the high price of proteome profiling.
• A discussion on affiliated trends, key drivers and challenges which are likely to impact the industry’s evolution, under a comprehensive SWOT framework.
• A detailed review of the impact of the COVID-19 pandemic on the overall proteome profiling services market.
• A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
• Application Area
• Drug Discovery
• Disease Diagnosis
• Others
• Type of Sponsor(s)
• Contract Research Organizations
• Pharmaceutical Companies
• Research and Academic Institutes
• Key Geographical Regions
• North America
• Europe
• Asia-Pacific and the Rest of the World 

Key companies covered in the report

• Biognosys
• BGI
• Bioproximity
• Cell Signaling Technology
• Creative Biolabs
• Creative Proteomics
• Cytomics
• i-DNA Biotechnology
• NMI TT Pharmaservices
• Poochon Scientific
• Proteomics International
• Proteome Factory
• Sciomics
• tebu-bio
• VProteomics

For more information please click on the following link:

https://www.rootsanalysis.com/reports/proteome-profiling-services.html

Other Recent Offerings

1. Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 – 2030
2. Peptide Therapeutics: Contract API Manufacturing Market, 2020 – 2030
3. Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Related Post
Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 billion in 2030, predicts Roots Analysis
The endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030, growing at an annualized rate of 30%, claims Roots Analysis
The High Energy / Hazardous Chemistry-based API manufacturing services market is estimated to be worth USD 29 billion in 2030, predicts Roots Analysis
The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis
The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis

Contact Information:

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis